ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,986.15
0.66%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Gamida Cell Ltd (GMDA)

  7. Gamida Cell Ltd (GMDA) Noticias

GMDA

Gamida Cell (GMDA)

Gamida Cell Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GMDA
FechaHoraFuenteTítuloSímboloCompañía
08/04/202406:30GlobeNewswire Inc.XORTX Welcomes New Member to the Board of DirectorsNASDAQ:GMDAGamida Cell Ltd
01/04/202407:00GlobeNewswire Inc.Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveNASDAQ:GMDAGamida Cell Ltd
27/03/202405:57IH Market NewsU.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early TradingNASDAQ:GMDAGamida Cell Ltd
14/02/202413:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GMDAGamida Cell Ltd
02/02/202415:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GMDAGamida Cell Ltd
29/01/202405:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GMDAGamida Cell Ltd
14/12/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GMDAGamida Cell Ltd
06/12/202316:24Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:GMDAGamida Cell Ltd
20/11/202316:27Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:GMDAGamida Cell Ltd
15/11/202316:24Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GMDAGamida Cell Ltd
14/11/202306:00GlobeNewswire Inc.Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:GMDAGamida Cell Ltd
20/10/202315:39Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:GMDAGamida Cell Ltd
11/10/202306:07Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GMDAGamida Cell Ltd
13/09/202315:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GMDAGamida Cell Ltd
01/09/202315:08Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GMDAGamida Cell Ltd
21/08/202316:00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:GMDAGamida Cell Ltd
15/08/202315:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GMDAGamida Cell Ltd
14/08/202315:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GMDAGamida Cell Ltd
11/07/202307:00Business WireData Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell’s Omisirge® (omidubicel-onlv)NASDAQ:GMDAGamida Cell Ltd
10/07/202313:00PR Newswire (US)STAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE OFFICERNASDAQ:GMDAGamida Cell Ltd
14/06/202315:30Business WireGamida Cell To Host Investor DayNASDAQ:GMDAGamida Cell Ltd
31/05/202315:30Business WireGamida Cell to Present Corporate Highlights at the Jefferies Healthcare ConferenceNASDAQ:GMDAGamida Cell Ltd
31/05/202306:00Business WireData To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual MeetingNASDAQ:GMDAGamida Cell Ltd
26/05/202315:20Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GMDAGamida Cell Ltd
25/05/202315:14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GMDAGamida Cell Ltd
22/05/202307:00Business WireGamida Cell Appoints Terry Coelho as CFONASDAQ:GMDAGamida Cell Ltd
16/05/202315:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GMDAGamida Cell Ltd
15/05/202316:14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GMDAGamida Cell Ltd
15/05/202315:05Business WireGamida Cell Reports First Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:GMDAGamida Cell Ltd
11/05/202316:20Business WireGamida Cell Announces the Date of Its First Quarter 2023 Financial Results and WebcastNASDAQ:GMDAGamida Cell Ltd
 Showing the most relevant articles for your search:NASDAQ:GMDA

Su Consulta Reciente

BIT
UB136G
UniCredit Bank
USOTC
RNSDF
Renault Sa Regie Nat (PK)
BIT
UB51N1
Unicredit Bank
XE
ARL0
Aareal Bank
USOTC
CLPBF
Coloplast AS (PK)
USOTC
NOURF
Northern Uranium (PK)
BIT
F29983
Vontobel Financial Produ...
BOV
PETRR213
PETRR213 Ex:17,2
NYSE
INGR
Ingredion
ASX
DM1
Desert Metals
BIT
P1DDD3
BNP Paribas Issuance
DOWI
DWGB
DJ UK Total Stock Market...
LBNK
HOODUSDT
HOOD AI
ASX
VTXOA
Vertex Minerals
COIN
KBDUSD
Kyberdyne
BIT
F18528
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados